In recent years, EIF5A2 has been shown to play a critical role in various cancers, including breast cancer, liver cancer, pancreatic cancer, and gastric cancer (Bai et al., 2018; Guan et al., 2019; Wu et al., 2020; Jiang et al., 2022). This evidence concerns the gene EIF5A2 and liver cancer.